Klebsiella pneumoniae clinical isolate coproducing SHV-2a, DHA-1, QnrB4, and AAC(6′)-Ib-cr determinants in France

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 4, 2009, Pages 462-463

  Corvec, Stéphane ^a,b   Crémet, Lise ^a   Caroff, Nathalie ^a,b   Dauvergne, Sandie ^b   Le Floch, Ronan ^a   Reynaud, Alain ^a,b   Lepelletier, Didier ^a,b   Bémer, Pascale ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

AmpC; Detection; ESBL; K. pneumoniae; Resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE 6' N ACETYLTRANSFERASE IB CR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAMASE DHA 1; BETA LACTAMASE SHV 2A; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; PROTEIN QNRB4; RIFAMPICIN; SULFAMETHOXAZOLE; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE REPORT; CATHETER INFECTION; ENZYME SYNTHESIS; FRANCE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL;

EID: 67651068499     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.04.001     Document Type: Article

References (9)

1. Barnaud G., Arlet G., Verdet C., Gaillot O., Lagrange P.H., and Philippon A. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42 (1998) 2352-2358
2. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18 (2008), Clinical and Laboratory Standards Institute, Wayne (PA)
4. Lartigue M.F., Zinsius C., Wenger A., Bille J., Poirel J., and Nordmann P. Extended-spectrum β-lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51 (2007) 2855-2860
5. Pérez-Pérez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40 (2002) 2153-2162
6. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46 (2002) 1-11
7. Sahly H., Navon-Venezia S., Roesler L., Hay A., Carmeli Y., Podschun R., Hennequin R., Forestier C., and Ofek I. Extended-spectrum β-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52 (2008) 3029-3034
8. Song W., Lee K.M., Kim H.S., Kim J.S., Kim J., Jeong S.H., and Roh K.H. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 β-lactamase at a burns intensive care unit. Int. J. Antimicrob. Agents 28 (2006) 520-524
9. Verdet C., Benzerara Y., Gautier V., Adam O., Ould-Hocine Z., and Arlet G. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob. Agents Chemother. 50 (2006) 607-617